Predictive Oncology aims to enhance drug discovery using its biobank and AI, following industry trends exemplified by Regeneron's 23andMe acquisition. Predictive Oncology Inc. is leveraging its ...
Medical University of South Carolina (MUSC) researchers discovered a biomarker in blood samples that with predictive analytics can determine which patients will develop COVID-19 symptoms. It remains ...
A new study of blood samples from nearly 200 COVID-19 patients reveals underlying metabolic changes that regulate how immune cells respond to the infection. These changes are associated with disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results